6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.
D000818:Animals; D003342:Corpus Striatum / Q000033:anatomy & histology / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D009410:Nerve Degeneration / Q000187:drug effects*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D013268:Stimulation, Chemical; D013378:Substantia Nigra / Q000033:anatomy & histology / Q000502:physiology*; D013577:Syndrome
D006892:Hydroxydopamines; D011955:Receptors, Drug; D004298:Dopamine